プラミペキソール (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "プラミペキソール" in Japanese language version.

refsWebsite

Global rank Japanese rank

4^th place

24^th place

2^nd place

6^th place

doi.org

“A review of the receptor-binding and pharmacokinetic properties of dopamine agonists”. Clinical Therapeutics 28 (8): 1065–78. (August 2006). doi:10.1016/j.clinthera.2006.08.004. PMID 16982285.
“Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. II. Agonist and antagonist properties at subtypes of dopamine D(2)-like receptor and alpha(1)/alpha(2)-adrenoceptor”. The Journal of Pharmacology and Experimental Therapeutics 303 (2): 805–14. (November 2002). doi:10.1124/jpet.102.039875. PMID 12388667.
“Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes”. The Journal of Pharmacology and Experimental Therapeutics 303 (2): 791–804. (November 2002). doi:10.1124/jpet.102.039867. PMID 12388666.
Weber, M; Chang W; Breier M; Ko D; Swerdlow NR (December 2008). “Heritable strain differences in sensitivity to the startle gating-disruptive effects of D2 but not D3 receptor stimulation”. Behav Pharmacol 19 (8): 786–795. doi:10.1097/FBP.0b013e32831c3b2b. PMC 3255557. PMID 19020413.
Chang, W; Weber M; Breier MR; Saint Marie RL; Hines SR; Swerdlow NR (February 2012). “Stereochemical and neuroanatomical selectivity of pramipexole effects on sensorimotor gating in rats”. Brain Res 1437: 69–76. doi:10.1016/j.brainres.2011.12.007. PMC 3268831. PMID 22227455.

“A review of the receptor-binding and pharmacokinetic properties of dopamine agonists”. Clinical Therapeutics 28 (8): 1065–78. (August 2006). doi:10.1016/j.clinthera.2006.08.004. PMID 16982285.
“Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. II. Agonist and antagonist properties at subtypes of dopamine D(2)-like receptor and alpha(1)/alpha(2)-adrenoceptor”. The Journal of Pharmacology and Experimental Therapeutics 303 (2): 805–14. (November 2002). doi:10.1124/jpet.102.039875. PMID 12388667.
“Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes”. The Journal of Pharmacology and Experimental Therapeutics 303 (2): 791–804. (November 2002). doi:10.1124/jpet.102.039867. PMID 12388666.
Weber, M; Chang W; Breier M; Ko D; Swerdlow NR (December 2008). “Heritable strain differences in sensitivity to the startle gating-disruptive effects of D2 but not D3 receptor stimulation”. Behav Pharmacol 19 (8): 786–795. doi:10.1097/FBP.0b013e32831c3b2b. PMC 3255557. PMID 19020413.
Chang, W; Weber M; Breier MR; Saint Marie RL; Hines SR; Swerdlow NR (February 2012). “Stereochemical and neuroanatomical selectivity of pramipexole effects on sensorimotor gating in rats”. Brain Res 1437: 69–76. doi:10.1016/j.brainres.2011.12.007. PMC 3268831. PMID 22227455.